-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $30

Benzinga·02/28/2025 15:57:28
Listen to the news
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $29 to $30.